论文部分内容阅读
目的:评价丹红注射液对心绞痛的临床疗效。方法:将符合诊断标准的64例不稳定型心绞痛患者随机分成治疗组和对照组各32例进行治.疗观察。治疗组给予丹红注射液静滴联合辛伐他汀口服,对照组给予葛根素注射液静滴,两组应用其他常规治疗药物相同。结果:治疗组在临床疗效、心电图改善方面均优于对照组(P<0.05)。结论:丹红注射液能有效缓解心绞痛和改善冠脉血流量,从而降低猝死率和心肌梗死的发生率,且无明显毒副作用,建议推广。
Objective: To evaluate the clinical effect of Danhong injection on angina pectoris. Methods: 64 patients with unstable angina pectoris who meet the diagnostic criteria were randomly divided into treatment group and control group, 32 cases were treated. The treatment group was given Danhong injection of intravenous infusion of simvastatin, the control group was given puerarin injection intravenously, the two groups of other conventional treatment of the same drug. Results: The treatment group was better than the control group in clinical efficacy and ECG improvement (P <0.05). Conclusion: Danhong injection can effectively relieve angina pectoris and improve coronary blood flow, thereby reducing the incidence of sudden death and myocardial infarction, and no obvious side effects, it is recommended to promote.